Research peptides are synthetic amino acid chains used in experimental settings, not approved medicines. They fall into six types: healing and repair, growth-hormone secretagogues, metabolic, mitochondrial, cognitive and cosmetic.
Knowing the type tells you what a peptide was studied for and how much human data exists. BPC-157 and MOTS-c are among the most-searched research peptides. Retatrutide is different: it is an investigational Eli Lilly drug in phase 3 trials, not approved, and it cannot legally be compounded.
As of October 2026:
- Retatrutide has phase 3 results but is not approved.
- BPC-157 has almost no human data: one clinical study in a 36-study review.
- Legal status is unsettled. An FDA advisory committee voted in July 2026 to recommend BPC-157, TB-500, MOTS-c and Semax, among others, for the 503A compounding list. The vote is advisory and does not change the law yet.
What are the six types of research peptides?
Researchers sort peptides by what they do, not by length or origin. The type points to the mechanism, and the mechanism points to the study design.
How to read it. Phase 3 results: large human trials have reported. Small trials: limited human data. Mostly animal: little human data. The last column is a rough read of published research, not a safety rating.
| Type | Examples | Studied for | Human data |
|---|---|---|---|
| Healing & repair | BPC-157, TB-500 | Tissue repair, new blood vessels, tendon and gut models | Mostly animal |
| Growth-hormone secretagogues | CJC-1295, Ipamorelin | Growth hormone release, body composition, recovery | Small trials |
| Metabolic | Retatrutide | Appetite, insulin, fat metabolism | Phase 3 results |
| Mitochondrial | MOTS-c, SS-31, SHLP-2 | Cell energy, insulin sensitivity, aging | Early, mixed |
| Cognitive & neurogenic | Semax, Selank | BDNF, neuroprotection, anxiety pathways | Limited trials |
| Cosmetic | GHK-Cu, AHK-Cu | Collagen, skin remodeling | Small skin studies |
What do healing peptides like BPC-157 and TB-500 do?
Healing peptides are among the most published classes in preclinical research. A 2025 systematic review of BPC-157 found 36 eligible studies: 35 preclinical and 1 clinical. It found no clinical safety data. Read more in our BPC-157 guide.
| Peptide | What it is | How it works | Studied for |
|---|---|---|---|
| BPC-157 | Synthetic peptide | Stimulates new blood vessels, modulates nitric oxide signaling | Tendon, muscle, gut, cornea |
| TB-500 | Synthetic fragment of thymosin beta-4 | Promotes actin polymerization and cell migration | Heart tissue, cornea, wound healing |
BPC-157 drives vascular growth. TB-500 drives cell motility. Researchers often study them side by side for musculoskeletal and systemic healing models.
- Tendon and ligament repair: BPC-157 shows consistent upregulation of growth factor receptors at injury sites.
- Gut integrity: BPC-157 has been studied for intestinal fistula healing and inflammatory bowel models.
- Systemic regeneration: TB-500 research covers cardiac tissue, corneal repair and wound healing.
What do growth-hormone secretagogues do?
They stimulate the pituitary gland to release growth hormone. Researchers favor the CJC-1295 and ipamorelin pair because it mimics the natural pulsatile pattern of GH release more closely than synthetic GH.
| Peptide | What it is | Research note |
|---|---|---|
| CJC-1295 | GHRH analog | Extends the half-life of growth-hormone-releasing hormone |
| Ipamorelin | GH-releasing peptide | Triggers GH pulses without significantly raising cortisol or prolactin |
| Hexarelin, GHRP-2, GHRP-6 | Other secretagogues | Each has a distinct receptor selectivity profile worth noting in study design |
The pair is a useful model for studying age-related GH decline, body composition and recovery physiology.
What do metabolic and mitochondrial peptides do?
This is a fast-moving research category in 2026. Retatrutide targets GLP-1, GIP and glucagon receptors at once. In the phase 3 TRIUMPH-1 trial (NEJM, 29 Sep 2026), adults with obesity lost 25.0% of body weight on the 12 mg dose over 80 weeks, versus 3.9% on placebo. It is still investigational and not approved. Comparing sources? See how retatrutide vendors compare on COAs.
| Peptide | Primary target | Key research benefit |
|---|---|---|
| Retatrutide | GLP-1 / GIP / glucagon receptors | Obesity, metabolic syndrome, weight loss |
| MOTS-c | Mitochondrial function, AMPK pathway | Insulin sensitivity, metabolic flexibility |
| SS-31 | Inner mitochondrial membrane | Oxidative stress reduction, aging resilience |
| SHLP-2 | Mitochondrial ribosome | Anti-aging, cellular energy optimization |
- MOTS-c is encoded in mitochondrial DNA, which makes it unique among research peptides.
- SS-31 targets the inner mitochondrial membrane to reduce oxidative stress.
What do Semax and Selank do?
They are two of the most studied cognitive peptides, researched for neuroprotection, BDNF modulation and anxiety reduction. Most published studies use nasal administration.
| Peptide | What it is | Research effect |
|---|---|---|
| Semax | ACTH analog | Upregulates BDNF and nerve growth factor; relevant to neuroplasticity and recovery |
| Selank | Synthetic analog of tuftsin | Anxiolytic effects without sedation |
Delivery is the hard part:
- Intranasal peptides must cross the nasal epithelium to reach the central nervous system.
- Formulation quality directly affects bioavailability.
- Peptide bioactivity depends on molecular conformation, not only the amino acid sequence, so cyclization and structural stability matter when sourcing.
Also studied in this class: Dihexa, a hepatocyte growth factor modulator with strong memory data in preclinical models, and Cerebrolysin-adjacent synthetic fragments in neurodegeneration models.
What do cosmetic peptides like GHK-Cu do?
GHK-Cu is one of the most documented cosmetic research peptides. It occurs naturally in human plasma and declines significantly with age, which is why longevity-focused skin research targets it.
| Peptide | Research role | Note |
|---|---|---|
| GHK-Cu | Collagen and elastin synthesis, dermal remodeling | Antioxidant activity; wound-healing and anti-inflammatory effects overlap with BPC-157 research |
| AHK-Cu | Variant of GHK-Cu | Promotes collagen and elastin synthesis |
| Matrixyl, Argireline | Collagen stimulation, expression-line reduction | Less exotic than GHK-Cu, with a stronger body of in vitro evidence for topical formulations |
Topical application is standard for cosmetic peptides. Systemic peptides like BPC-157 are typically studied via subcutaneous or oral routes.
What are synthetic analogs and modified peptides?
Peptide research faces real challenges with oral bioavailability and fast breakdown by enzymes. Labs respond by modifying the sequence. Common changes:
- N-methylation
- PEGylation
- Cyclization
- D-amino acid substitution
CJC-1295 with DAC (Drug Affinity Complex) is the textbook example. DAC binds albumin in the blood and extends half-life from minutes to days. Treat modified analogs as separate compounds from their parent sequences: receptor binding and metabolic fate can differ significantly.
How do you check that a research peptide is good quality?
Sourcing is the biggest variable in research quality. Many suppliers provide batch-generic or Photoshopped Certificates of Analysis (COAs). To compare vendors by their lab reports, check these four things:
| Check | Good sign | Red flag |
|---|---|---|
| Purity | Above 98% | A summary percentage only |
| Batch | COA references the batch number on your vial | Generic lot, no vial number |
| Method | Batch-specific HPLC and mass spectrometry | One method, or none stated |
| Chromatogram | Raw trace with a single dominant peak at the correct retention time | Refuses to share the raw file |
Ask for the raw chromatogram, not just the purity number. A clean single peak tells you far more than a figure on a PDF.
How do you store and handle lyophilized peptides?
- Store lyophilized powder at -20°C for long-term stability.
- Reconstitute with bacteriostatic water to prevent microbial growth.
- Keep reconstituted vials at 2–8°C and use within the manufacturer’s recommended window.
- Swirl gently to dissolve. Never shake: agitation denatures peptide bonds.
- Check that the COA matches the batch number on your vial.
Key takeaways
| Point | Details |
|---|---|
| Six functional classes | Healing, GHS, metabolic, mitochondrial, cognitive and cosmetic peptides each require distinct protocols. |
| BPC-157: mostly animal data | A 2025 systematic review found 36 eligible studies: 35 preclinical, 1 clinical, and no clinical safety data. |
| Retatrutide has phase 3 data | TRIUMPH-1: 25.0% weight loss at 12 mg vs 3.9% on placebo over 80 weeks. Still investigational. |
| COA quality sets data reliability | Batch-specific HPLC and mass-spec data above 98% purity is the minimum standard. |
| Modified analogs are distinct compounds | Changes like DAC or PEGylation alter receptor binding and half-life, so they need separate study design. |
Where to go next for each type
- Healing: BPC-157, TB-500, BPC-157 vs TB-500 and the Wolverine stack evidence
- Growth hormone: CJC-1295 and ipamorelin
- Metabolic and mitochondrial: retatrutide vendors and what the MOTS-c research shows
- Cognitive: Semax vs Selank
- Cosmetic: GHK-Cu and GHK-Cu cream
- Basics and sourcing: what peptides are and vendors compared by lab reports
Why I think most researchers start in the wrong category
Most people gravitate toward healing peptides first, usually BPC-157, because the published literature is dense and accessible. A reasonable start. But the more I have worked through the research, the more I believe the mitochondrial peptide class is where the most underappreciated science currently lives.
MOTS-c is encoded in mitochondrial DNA. That structural origin alone separates it from every other peptide class and raises questions about evolutionary function that most researchers have not seriously engaged with yet. SS-31 targets the inner mitochondrial membrane with a specificity that most systemic peptides cannot match. The SHLP family is barely a decade into serious study. These are not fringe compounds. They are foundational to understanding cellular aging, and they are being overshadowed by the GLP-1 wave.
The regulatory environment is also shifting in ways that matter. Several GHS peptides have faced increased scrutiny from the FDA, and researchers relying on gray-market sourcing for compounds like CJC-1295 or Ipamorelin face real supply chain uncertainty. Building a research program around compounds with clearer regulatory trajectories is not timid. It is practical.
My honest recommendation: learn the functional classification framework before you pick a compound. The category tells you the mechanism. The mechanism tells you the protocol. The protocol determines whether your data means anything.
FAQ
What are research peptides, exactly?
Research peptides are synthetic chains of 2–50 amino acids produced via Solid-Phase Peptide Synthesis and used in experimental studies. They are not FDA-approved medicines and do not carry sterility guarantees for human use.
What are the main peptide categories in 2026?
The six main 2026 peptide classifications are healing and repair, growth-hormone secretagogues, metabolic, mitochondrial, cognitive and neurogenic, and cosmetic. Each class maps to a distinct biological mechanism and research application.
Which research peptide is best for anti-aging studies?
GHK-Cu leads cosmetic and dermal anti-aging research, while MOTS-c and SS-31 are the top mitochondrial peptides for cellular aging models. The best choice depends on whether your research targets skin biology or systemic cellular resilience.
How do I know if a research peptide COA is legitimate?
A legitimate COA references the specific batch number on your vial and includes raw HPLC chromatogram data alongside mass-spectrometry confirmation. Purity above 98% is the standard threshold for credible research-grade peptides.
What makes retatrutide different from earlier GLP-1 peptides?
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, while earlier compounds like Semaglutide target only GLP-1. That triple-receptor activity produces greater metabolic correction and is why Retatrutide is in late-stage clinical trials.
How many types of peptides are there?
There is no official count. This guide uses six functional classes: healing and repair, growth-hormone secretagogues, metabolic, mitochondrial, cognitive and cosmetic. Other sources sort peptides by structure (linear, cyclic, modified) or by origin (natural or synthetic).
Are research peptides legal?
Research peptides are sold labeled for research use only, which means they are not approved for human use. In July 2026 an FDA advisory committee voted to recommend BPC-157, TB-500, MOTS-c, Semax and others for the 503A compounding list. The vote is advisory and does not change the law yet. Rules differ by country.
Are research peptides safe for humans?
Safety in humans is not established for most research peptides. A 2025 systematic review of BPC-157 found no clinical safety data. Unregulated products also carry contamination and purity risks, which is why batch-specific lab reports matter.
Sources
- Vasireddi N, et al. Emerging use of BPC-157 in orthopaedic sports medicine: a systematic review. HSS J. 2025;21(4):485–495. doi:10.1177/15563316251355551
- Jastreboff AM, et al. Retatrutide, a triple hormone receptor agonist, for treatment of obesity (TRIUMPH-1). N Engl J Med. 2026. doi:10.1056/NEJMoa2604169
- Bass, Berry & Sims. FDA advisory committee recommends six peptides for compounding (July 2026 meeting).
- NCBI Bookshelf: peptide overview (NBK562260).
- Peptide bioactivity and conformation (RSC, 2026).
- Peptide stability and bioavailability challenges (MDPI Biomedicines, 2026).